These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25052901)

  • 1. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    He S; Pan YN; Zhang ZY
    Diabetes Res Clin Pract; 2014 Sep; 105(3):e9. PubMed ID: 25052901
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Xu et al.: Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    He F; Zhang Y; Sun L
    Diabetes Res Clin Pract; 2014 May; 104(2):e33. PubMed ID: 24602352
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy.
    Xu Q; Pan J; Yu J; Liu X; Liu L; Zuo X; Wu P; Deng H; Zhang J; Ji A
    Diabetes Res Clin Pract; 2013 Aug; 101(2):99-105. PubMed ID: 23664235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on Deng et al. entitled "meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy".
    Lu E; Meng Y
    Endocrine; 2014 Dec; 47(3):973-4. PubMed ID: 25027297
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
    Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
    Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Li MX; Wang Y; Wang Y
    Neurosci Lett; 2015 May; 594():23-9. PubMed ID: 25800109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy.
    Deng H; Yin J; Zhang J; Xu Q; Liu X; Liu L; Wu Z; Ji A
    Endocrine; 2014 Aug; 46(3):445-54. PubMed ID: 24522613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sawangjit R; Thongphui S; Chaichompu W; Phumart P
    J Altern Complement Med; 2020 Dec; 26(12):1117-1129. PubMed ID: 32716261
    [No Abstract]   [Full Text] [Related]  

  • 10. Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.
    Jiang DQ; Xu LC; Jiang LL; Li MX; Wang Y
    Medicine (Baltimore); 2018 Jul; 97(27):e11390. PubMed ID: 29979431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-Lipoic Acid for Treatment of Diabetic Peripheral Neuropathy.
    Bartkoski S; Day M
    Am Fam Physician; 2016 May; 93(9):786. PubMed ID: 27175957
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological significance of alpha lipoic acid in up to date treatment of diabetic neuropathy].
    Becić F; Kapić E; Rakanović-Todić M
    Med Arh; 2008; 62(1):45-8. PubMed ID: 18543755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
    Papanas N; Maltezos E
    Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy].
    Internist (Berl); 1994 Jun; 35(6 Alpha-liponsa):1-4. PubMed ID: 9532228
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
    Vereşiu IA
    Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Lipoic acid in NIDDM patients with cardiac autonomic neuropathy.
    Köbberling J; Hompesch M
    Diabetes Care; 1997 Dec; 20(12):1918-20. PubMed ID: 9405919
    [No Abstract]   [Full Text] [Related]  

  • 17. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
    Strokov IA; Phokina AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
    Wang XT; Lin HX; Xu SA; Lu YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylcobalamin on diabetic autonomic neuropathy as assessed by power spectral analysis of heart rate variations.
    Yoshioka K; Tanaka K
    Horm Metab Res; 1995 Jan; 27(1):43-4. PubMed ID: 7729794
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.
    Ran GL; Li YP; Lu LC; Lan SH
    J Diabetes Complications; 2024 Feb; 38(2):108691. PubMed ID: 38330524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.